dChan - Q Origins Project Archive

✅Chloroquine is a potent inhibitor of SARS coronavirus infection and spread https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/

✅Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study , https://www.preprints.org/manuscript/202005.0057/v1

✅Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France https://www.sciencedirect.com/science/article/pii/S1477893920302179 , http://archive.is/VEdFi

Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. https://www.ncbi.nlm.nih.gov/pubmed/15320751

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/

✅Chloroquine Is a Zinc Ionophore https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182877/

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001837/ , Drug Des Devel Ther. 2018; 12: 1685–1695, Published online 2018 Jun 11. doi: 10.2147/DDDT.S166893

https://pubmed.ncbi.nlm.nih.gov/16115318/

Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread

Here's the new study incoming:

https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19

NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

To keep track of the study, look here:

https://clinicaltrials.gov/ct2/show/NCT04358068

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

Collaborator: Teva Pharmaceuticals Industries LTD

https://www.ncbi.nlm.nih.gov/pubmed/16115318

and

https://www.ncbi.nlm.nih.gov/pubmed/15351731